T Yamamoto, K Nishioka. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, TopicalAdultErythema/pathologyHumansImmunosuppressive Agents/therapeutic useMaleMouth Diseases/drug therapyPhototherapyPsoriasis/drug therapySeverity of Illness IndexTacrolimus/therapeutic use
Substances: See more » Immunosuppressive AgentsTacrolimus
Year: 2006 PMID: 16987275 DOI: 10.1111/j.1468-3083.2006.01630.x
Source DB: PubMed Journal: J Eur Acad Dermatol Venereol ISSN: 0926-9959 Impact factor: 6.166